Coeptis Therapeutics Holdings Inc./$COEP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
Ticker
$COEP
Sector
Primary listing
Employees
5
Headquarters
Website
COEP Metrics
BasicAdvanced
$79M
-
-$2.81
-0.47
-
Price and volume
Market cap
$79M
Beta
-0.47
52-week high
$21.41
52-week low
$6.26
Average daily volume
47K
Financial strength
Current ratio
4.157
Quick ratio
3.596
Long term debt to equity
1.066
Total debt to equity
1.911
Interest coverage (TTM)
-20.30%
Profitability
EBITDA (TTM)
-11.862
Gross margin (TTM)
86.75%
Net profit margin (TTM)
-874.29%
Operating margin (TTM)
-956.97%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
-65.05%
Return on equity (TTM)
-136.90%
Valuation
Price to revenue (TTM)
39.209
Price to book
5.35
Price to tangible book (TTM)
5.73
Price to free cash flow (TTM)
-6.212
Free cash flow yield (TTM)
-16.10%
Free cash flow per share (TTM)
-2.032
Growth
Earnings per share change (TTM)
-49.29%
3-year earnings per share growth (CAGR)
-62.31%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Coeptis Therapeutics Holdings Inc. stock?
Coeptis Therapeutics Holdings Inc. (COEP) has a market cap of $79M as of April 13, 2026.
What is the P/E ratio for Coeptis Therapeutics Holdings Inc. stock?
The price to earnings (P/E) ratio for Coeptis Therapeutics Holdings Inc. (COEP) stock is 0 as of April 13, 2026.
Does Coeptis Therapeutics Holdings Inc. stock pay dividends?
No, Coeptis Therapeutics Holdings Inc. (COEP) stock does not pay dividends to its shareholders as of April 13, 2026.
When is the next Coeptis Therapeutics Holdings Inc. dividend payment date?
Coeptis Therapeutics Holdings Inc. (COEP) stock does not pay dividends to its shareholders.
What is the beta indicator for Coeptis Therapeutics Holdings Inc.?
Coeptis Therapeutics Holdings Inc. (COEP) has a beta rating of -0.47. This means that it has an inverse relation to market volatility.